BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rossello X, Yellon DM. The RISK pathway and beyond. Basic Res Cardiol 2018;113:2. [PMID: 29143177 DOI: 10.1007/s00395-017-0662-x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 114] [Article Influence: 18.6] [Reference Citation Analysis]
Number Citing Articles
1 Gao Q, Deng H, Yang Z, Yang Q, Zhang Y, Yuan X, Zeng M, Guo M, Zeng W, Jiang X, Yu B. Sodium danshensu attenuates cerebral ischemia–reperfusion injury by targeting AKT1. Front Pharmacol 2022;13:946668. [DOI: 10.3389/fphar.2022.946668] [Reference Citation Analysis]
2 Mauerhofer C, Afonyushkin T, Oskolkova OV, Hellauer K, Gesslbauer B, Schmerda J, Ke Y, Zimmer A, Birukova AA, Birukov KG, Bochkov V. Low Concentrations of Oxidized Phospholipids Increase Stress Tolerance of Endothelial Cells. Antioxidants 2022;11:1741. [DOI: 10.3390/antiox11091741] [Reference Citation Analysis]
3 Gallinat A, Badimon L. DJ-1 interacts with the ectopic ATP-synthase in endothelial cells during acute ischemia and reperfusion. Sci Rep 2022;12:12753. [PMID: 35882968 DOI: 10.1038/s41598-022-16998-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Kim ST, Helmers MR, Iyengar A, Han JJ, Patrick WL, Weingarten N, Herbst DA, Atluri P. Interaction between donor obesity and prolonged donor ischemic time in heart transplantation. J Cardiol 2022:S0914-5087(22)00159-9. [PMID: 35835640 DOI: 10.1016/j.jjcc.2022.06.013] [Reference Citation Analysis]
5 Cheng X, Li H, Yan Z, Liu J, Hu Z. Ischemic limb preconditioning-induced anti-arrhythmic effect in reperfusion-induced myocardial injury: is it mediated by the RISK or SAFE pathway? Pflugers Arch 2022. [PMID: 35695933 DOI: 10.1007/s00424-022-02716-5] [Reference Citation Analysis]
6 Zafonte RD, Wang L, Arbelaez CA, Dennison R, Teng YD. Medical Gas Therapy for Tissue, Organ, and CNS Protection: A Systematic Review of Effects, Mechanisms, and Challenges. Adv Sci (Weinh) 2022;9:e2104136. [PMID: 35243825 DOI: 10.1002/advs.202104136] [Reference Citation Analysis]
7 Su X, Zhou M, Li Y, Zhang J, An N, Yang F, Zhang G, Yuan C, Chen H, Wu H, Xing Y. Protective effects of natural products against myocardial ischemia/reperfusion: Mitochondria-targeted therapeutics. Biomed Pharmacother 2022;149:112893. [PMID: 35366532 DOI: 10.1016/j.biopha.2022.112893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Liao S, Luo J, Kadier T, Ding K, Chen R, Meng Q. Mitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury. Front Pharmacol 2022;13:854994. [PMID: 35370747 DOI: 10.3389/fphar.2022.854994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
9 Chen Z, Tang WJ, Zhou YH, Chen ZM, Liu K. Andrographolide inhibits non-small cell lung cancer cell proliferation through the activation of the mitochondrial apoptosis pathway and by reprogramming host glucose metabolism. Ann Transl Med 2021;9:1701. [PMID: 34988210 DOI: 10.21037/atm-21-5975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pedersen S, Larsen KO, Christensen AH, Svane IM, Zerahn B, Ellebaek E. Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting. Acta Oncol 2022;61:45-51. [PMID: 34666597 DOI: 10.1080/0284186X.2021.1992010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Díaz-Vesga MC, Zúñiga-Cuevas Ú, Ramírez-Reyes A, Herrera-Zelada N, Palomo I, Bravo-Sagua R, Riquelme JA. Potential Therapies to Protect the Aging Heart Against Ischemia/Reperfusion Injury. Front Cardiovasc Med 2021;8:770421. [PMID: 34869687 DOI: 10.3389/fcvm.2021.770421] [Reference Citation Analysis]
12 Perveen S, Rossin D, Vitale E, Rosso R, Vanni R, Cristallini C, Rastaldo R, Giachino C. Therapeutic Acellular Scaffolds for Limiting Left Ventricular Remodelling-Current Status and Future Directions. Int J Mol Sci 2021;22:13054. [PMID: 34884856 DOI: 10.3390/ijms222313054] [Reference Citation Analysis]
13 Majka M, Kleibert M, Wojciechowska M. Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart's Vulnerability to Ischemia-Reperfusion Injury. Cells 2021;10:3331. [PMID: 34943838 DOI: 10.3390/cells10123331] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
14 Torregroza C, Glashoerster CO, Feige K, Stroethoff M, Raupach A, Heinen A, Hollmann MW, Huhn R. Mediation of the Cardioprotective Effects of Mannitol Discovered, with Refutation of Common Protein Kinases. Int J Mol Sci 2021;22:12471. [PMID: 34830353 DOI: 10.3390/ijms222212471] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Beà A, Valero JG, Irazoki A, Lana C, López-Lluch G, Portero-Otín M, Pérez-Galán P, Inserte J, Ruiz-Meana M, Zorzano A, Llovera M, Sanchis D. Cardiac fibroblasts display endurance to ischemia, high ROS control and elevated respiration regulated by the JAK2/STAT pathway. FEBS J 2021. [PMID: 34796659 DOI: 10.1111/febs.16283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Thu VT, Kim HK. Majonoside-R2 Postconditioning Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Attenuating the Expression of HIF1α and Activating RISK Pathway. J Med Food 2021;24:1222-9. [PMID: 34714126 DOI: 10.1089/jmf.2021.K.0083] [Reference Citation Analysis]
17 Hu Z, Ju F, Du L, Abbott GW. Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death. Cardiovasc Diabetol 2021;20:199. [PMID: 34607570 DOI: 10.1186/s12933-021-01392-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
18 Amoni M, Dries E, Ingelaere S, Vermoortele D, Roderick HL, Claus P, Willems R, Sipido KR. Ventricular Arrhythmias in Ischemic Cardiomyopathy-New Avenues for Mechanism-Guided Treatment. Cells 2021;10:2629. [PMID: 34685609 DOI: 10.3390/cells10102629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Femminò S, D'Ascenzo F, Ravera F, Comità S, Angelini F, Caccioppo A, Franchin L, Grosso A, Thairi C, Venturelli E, Cavallari C, Penna C, De Ferrari GM, Camussi G, Pagliaro P, Brizzi MF. Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties. Int J Mol Sci 2021;22:10270. [PMID: 34638611 DOI: 10.3390/ijms221910270] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Berg PC, Hansson ÅML, Røsand Ø, Marwarha G, Høydal MA. Overexpression of Neuron-Derived Orphan Receptor 1 (NOR-1) Rescues Cardiomyocytes from Cell Death and Improves Viability after Doxorubicin Induced Stress. Biomedicines 2021;9:1233. [PMID: 34572418 DOI: 10.3390/biomedicines9091233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ferenczyová K, Kindernay L, Vlkovičová J, Kaločayová B, Rajtík T, Barteková M. Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart. Antioxidants (Basel) 2021;10:1390. [PMID: 34573022 DOI: 10.3390/antiox10091390] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Franco-Vadillo A, Toledo-Blass M, Rivera-Herrera Z, Guevara-Balcazar G, Orihuela-Rodriguez O, Morales-Carmona JA, Kormanovski-Kovzova A, Lopez-Sanchez P, Rubio-Gayosso I, Castillo-Hernandez MDC. Cannabidiol-mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage. Pharmacol Res Perspect 2021;9:e00784. [PMID: 34176244 DOI: 10.1002/prp2.784] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
23 Boovarahan SR, Venkatasubramanian H, Sharma N, Venkatesh S, Prem P, Kurian GA. Inhibition of PI3K/mTOR/KATP channel blunts sodium thiosulphate preconditioning mediated cardioprotection against ischemia-reperfusion injury. Arch Pharm Res 2021;44:605-20. [PMID: 34170496 DOI: 10.1007/s12272-021-01339-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Parra-Flores P, Espitia-Corredor J, Espinoza-Pérez C, Queirolo C, Ayala P, Brüggendieck F, Salas-Hernández A, Pardo-Jiménez V, Díaz-Araya G. Toll-Like Receptor 4 Activation Prevents Rat Cardiac Fibroblast Death Induced by Simulated Ischemia/Reperfusion. Front Cardiovasc Med 2021;8:660197. [PMID: 34169098 DOI: 10.3389/fcvm.2021.660197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 D'Ascenzo F, Femminò S, Ravera F, Angelini F, Caccioppo A, Franchin L, Grosso A, Comità S, Cavallari C, Penna C, De Ferrari GM, Camussi G, Pagliaro P, Brizzi MF. Extracellular vesicles from patients with Acute Coronary Syndrome impact on ischemia-reperfusion injury. Pharmacol Res 2021;170:105715. [PMID: 34111564 DOI: 10.1016/j.phrs.2021.105715] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Lieder HR, Braczko F, Gedik N, Stroetges M, Heusch G, Kleinbongard P. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes. Basic Res Cardiol 2021;116:27. [PMID: 33876304 DOI: 10.1007/s00395-021-00868-6] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
27 Zicola E, Arrigo E, Mancardi D. H2S Pretreatment Is Promigratory and Decreases Ischemia/Reperfusion Injury in Human Microvascular Endothelial Cells. Oxid Med Cell Longev 2021;2021:8886666. [PMID: 33953839 DOI: 10.1155/2021/8886666] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Lotz C, Herrmann J, Notz Q, Meybohm P, Kehl F. Mitochondria and Pharmacologic Cardiac Conditioning-At the Heart of Ischemic Injury. Int J Mol Sci 2021;22:3224. [PMID: 33810024 DOI: 10.3390/ijms22063224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Abel ED. mTOR Mediated Metabolic Rewiring and Ischemic Preconditioning, its Complicated. Circ Res 2021;128:652-4. [PMID: 34219792 DOI: 10.1161/circresaha.121.318874] [Reference Citation Analysis]
30 Roth S, Torregroza C, Feige K, Preckel B, Hollmann MW, Weber NC, Huhn R. Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications. Int J Mol Sci 2021;22:2519. [PMID: 33802308 DOI: 10.3390/ijms22052519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Raupach A, Feige K, Reiter C, Brandenburger T, Heinen N, Heinen A, Hollmann MW, Huhn R, Torregroza C. Remote ischemic preconditioning does not induce activation of Akt and STAT5 in the rat heart. Exp Ther Med 2021;21:432. [PMID: 33747171 DOI: 10.3892/etm.2021.9849] [Reference Citation Analysis]
32 Pearce L, Davidson SM, Yellon DM. Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response. Basic Res Cardiol 2021;116:12. [PMID: 33629195 DOI: 10.1007/s00395-021-00852-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
33 Horvath O, Ordog K, Bruszt K, Deres L, Gallyas F, Sumegi B, Toth K, Halmosi R. BGP-15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats. Oxid Med Cell Longev 2021;2021:1250858. [PMID: 33564362 DOI: 10.1155/2021/1250858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Dambrova M, Zuurbier CJ, Borutaite V, Liepinsh E, Makrecka-Kuka M. Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury. Free Radic Biol Med 2021;165:24-37. [PMID: 33484825 DOI: 10.1016/j.freeradbiomed.2021.01.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
35 Torregroza C, Roth S, Feige K, Lurati Buse G, Hollmann MW, Huhn R. [Perioperative cardioprotection - From bench to bedside : Current experimental evidence and possible reasons for the limited translation into the clinical setting]. Anaesthesist 2021;70:401-12. [PMID: 33464375 DOI: 10.1007/s00101-020-00912-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Rozier R, Paul R, Madji Hounoum B, Villa E, Mhaidly R, Chiche J, Verhoeyen E, Marchetti S, Vandenberghe A, Raucoules M, Carles M, Ricci JE. Pharmacological preconditioning protects from ischemia/reperfusion-induced apoptosis by modulating Bcl-xL expression through a ROS-dependent mechanism. FEBS J 2021;288:3547-69. [PMID: 33340237 DOI: 10.1111/febs.15675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Roth S, Torregroza C, Huhn R, Hollmann MW, Preckel B. Perioperative Cardioprotection: Clinical Implications. Anesth Analg 2020;131:1751-64. [PMID: 33186162 DOI: 10.1213/ANE.0000000000005234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
38 Smit SE, Manirafasha C, Marais E, Johnson R, Huisamen B. Cardioprotective Function of Green Rooibos (Aspalathus linearis) Extract Supplementation in Ex Vivo Ischemic Prediabetic Rat Hearts. Planta Med 2020. [PMID: 33285593 DOI: 10.1055/a-1239-9236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 He Z, Davidson SM, Yellon DM. The importance of clinically relevant background therapy in cardioprotective studies. Basic Res Cardiol 2020;115:69. [PMID: 33188438 DOI: 10.1007/s00395-020-00830-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
40 Zhao HH, Han QX, Ding XN, Yan JY, Li Q, Zhang D, Zhu HY. Critical hubs of renal ischemia-reperfusion injury: endoplasmic reticulum-mitochondria tethering complexes. Chin Med J (Engl) 2020;133:2599-609. [PMID: 32960842 DOI: 10.1097/CM9.0000000000001091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Aránguiz P, Romero P, Vásquez F, Flores-Vergara R, Aravena D, Sánchez G, González M, Olmedo I, Pedrozo Z. Polycystin-1 mitigates damage and regulates CTGF expression through AKT activation during cardiac ischemia/reperfusion. Biochim Biophys Acta Mol Basis Dis 2021;1867:165986. [PMID: 33065236 DOI: 10.1016/j.bbadis.2020.165986] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Wang J, Zhou H. Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury. Acta Pharm Sin B 2020;10:1866-79. [PMID: 33163341 DOI: 10.1016/j.apsb.2020.03.004] [Cited by in Crossref: 77] [Cited by in F6Publishing: 81] [Article Influence: 38.5] [Reference Citation Analysis]
43 Singhanat K, Apaijai N, Jaiwongkam T, Kerdphoo S, Chattipakorn SC, Chattipakorn N. Melatonin as a therapy in cardiac ischemia-reperfusion injury: Potential mechanisms by which MT2 activation mediates cardioprotection. J Adv Res 2021;29:33-44. [PMID: 33842003 DOI: 10.1016/j.jare.2020.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
44 Bellis A, Mauro C, Barbato E, Di Gioia G, Sorriento D, Trimarco B, Morisco C. The Rationale of Neprilysin Inhibition in Prevention of Myocardial Ischemia-Reperfusion Injury during ST-Elevation Myocardial Infarction. Cells 2020;9:E2134. [PMID: 32967374 DOI: 10.3390/cells9092134] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
45 Deng Y, Chen S, Zhang M, Li C, He J, Tan Y. AMPKα2 Overexpression Reduces Cardiomyocyte Ischemia-Reperfusion Injury Through Normalization of Mitochondrial Dynamics. Front Cell Dev Biol 2020;8:833. [PMID: 32984328 DOI: 10.3389/fcell.2020.00833] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Jankowski M, Broderick TL, Gutkowska J. The Role of Oxytocin in Cardiovascular Protection. Front Psychol 2020;11:2139. [PMID: 32982875 DOI: 10.3389/fpsyg.2020.02139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
47 Xu W, Li L, Zhang L. NAD+ Metabolism as an Emerging Therapeutic Target for Cardiovascular Diseases Associated With Sudden Cardiac Death. Front Physiol 2020;11:901. [PMID: 32903597 DOI: 10.3389/fphys.2020.00901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
48 Liu X, Xu C, Xu L, Li X, Sun H, Xue M, Li T, Yu X, Sun B, Chen L. Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway. Metabolism 2020;111:154334. [PMID: 32777444 DOI: 10.1016/j.metabol.2020.154334] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
49 Penna C, Aragno M, Cento AS, Femminò S, Russo I, Bello FD, Chiazza F, Collotta D, Alves GF, Bertinaria M, Zicola E, Mercurio V, Medana C, Collino M, Pagliaro P. Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades. Oxid Med Cell Longev 2020;2020:9219825. [PMID: 32832010 DOI: 10.1155/2020/9219825] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
50 Yi T, Wu X, Li H. Ubiquinol-cytochrome c reductase core protein 1 overexpression protects H9c2 cardiac cells against mimic ischemia/reperfusion injury through PI3K/Akt/GSK-3β pathway. Biochem Biophys Res Commun 2020;529:904-9. [PMID: 32819597 DOI: 10.1016/j.bbrc.2020.06.089] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
51 Gáspár R, Gömöri K, Kiss B, Szántai Á, Pálóczi J, Varga ZV, Pipis J, Váradi B, Ágg B, Csont T, Ferdinandy P, Barteková M, Görbe A. Decorin Protects Cardiac Myocytes against Simulated Ischemia/Reperfusion Injury. Molecules 2020;25:E3426. [PMID: 32731559 DOI: 10.3390/molecules25153426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
52 Gallo S, Spilinga M, Casanova E, Bonzano A, Boccaccio C, Comoglio PM, Crepaldi T. The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3. Int J Mol Sci 2020;21:E5258. [PMID: 32722178 DOI: 10.3390/ijms21155258] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
53 Rout A, Tantry US, Novakovic M, Sukhi A, Gurbel PA. Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction. Expert Opin Pharmacother 2020;21:1851-65. [PMID: 32659185 DOI: 10.1080/14656566.2020.1787987] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
54 Wu Y, Chen AW, Goodnough CL, Lu Y, Zhang Y, Gross ER. IcyHot analgesic topical cream limits cardiac injury in rodents. Transl Res 2021;227:42-52. [PMID: 32629175 DOI: 10.1016/j.trsl.2020.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Pearce L, Davidson SM, Yellon DM. The cytokine storm of COVID-19: a spotlight on prevention and protection. Expert Opin Ther Targets 2020;24:723-30. [PMID: 32594778 DOI: 10.1080/14728222.2020.1783243] [Cited by in Crossref: 33] [Cited by in F6Publishing: 53] [Article Influence: 16.5] [Reference Citation Analysis]
56 Yao W, Han X, Ge M, Chen C, Xiao X, Li H, Hei Z. N6-methyladenosine (m6A) methylation in ischemia-reperfusion injury. Cell Death Dis 2020;11:478. [PMID: 32581252 DOI: 10.1038/s41419-020-2686-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
57 Torregroza C, Feige K, Schneider L, Bunte S, Stroethoff M, Heinen A, Hollmann MW, Huhn R, Raupach A. Influence of Hyperglycemia on Dexmedetomidine-Induced Cardioprotection in the Isolated Perfused Rat Heart. J Clin Med 2020;9:E1445. [PMID: 32413983 DOI: 10.3390/jcm9051445] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
58 Crisafulli A, Pagliaro P, Roberto S, Cugusi L, Mercuro G, Lazou A, Beauloye C, Bertrand L, Hausenloy DJ, Aragno M, Penna C. Diabetic Cardiomyopathy and Ischemic Heart Disease: Prevention and Therapy by Exercise and Conditioning. Int J Mol Sci 2020;21:E2896. [PMID: 32326182 DOI: 10.3390/ijms21082896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
59 Qi X, Wang J. Melatonin improves mitochondrial biogenesis through the AMPK/PGC1α pathway to attenuate ischemia/reperfusion-induced myocardial damage. Aging (Albany NY) 2020;12:7299-312. [PMID: 32305957 DOI: 10.18632/aging.103078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
60 Yang G, Yang Y, Li Y, Hu Z. Remote liver ischaemic preconditioning protects rat brain against cerebral ischaemia-reperfusion injury by activation of an AKT-dependent pathway. Exp Physiol 2020;105:852-63. [PMID: 32134522 DOI: 10.1113/EP088394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Wang J, Toan S, Zhou H. Mitochondrial quality control in cardiac microvascular ischemia-reperfusion injury: New insights into the mechanisms and therapeutic potentials. Pharmacol Res 2020;156:104771. [PMID: 32234339 DOI: 10.1016/j.phrs.2020.104771] [Cited by in Crossref: 54] [Cited by in F6Publishing: 81] [Article Influence: 27.0] [Reference Citation Analysis]
62 Aceros H, Der Sarkissian S, Borie M, Pinto Ribeiro RV, Maltais S, Stevens LM, Noiseux N. Novel heat shock protein 90 inhibitor improves cardiac recovery in a rodent model of donation after circulatory death. J Thorac Cardiovasc Surg 2020:S0022-5223(20)30707-8. [PMID: 32354629 DOI: 10.1016/j.jtcvs.2020.03.042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
63 Boengler K, Schlüter KD, Schermuly RT, Schulz R. Cardioprotection in right heart failure. Br J Pharmacol 2020;177:5413-31. [PMID: 31995639 DOI: 10.1111/bph.14992] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
64 Li P, Hu F, Cao X, Luo L, Tu Q. Melatonin receptor protects cardiomyocyte against oxidative stress-induced apoptosis through the MAPK-ERK signaling pathway. Journal of Receptors and Signal Transduction 2020;40:117-25. [DOI: 10.1080/10799893.2020.1719151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
65 Zhang Y, Zhang H, Shi W, Wang W. Mief1 augments thyroid cell dysfunction and apoptosis through inhibiting AMPK-PTEN signaling pathway. J Recept Signal Transduct Res 2020;40:15-23. [PMID: 31960779 DOI: 10.1080/10799893.2020.1716799] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Ma S, Dong Z. Melatonin Attenuates Cardiac Reperfusion Stress by Improving OPA1-Related Mitochondrial Fusion in a Yap-Hippo Pathway-Dependent Manner. J Cardiovasc Pharmacol 2019;73:27-39. [PMID: 30418242 DOI: 10.1097/FJC.0000000000000626] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
67 Zhou H, Toan S. Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury. Biomolecules 2020;10:E85. [PMID: 31948043 DOI: 10.3390/biom10010085] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 26.0] [Reference Citation Analysis]
68 Ferenczyova K, Kalocayova B, Kindernay L, Jelemensky M, Balis P, Berenyiova A, Zemancikova A, Farkasova V, Sykora M, Tothova L, Jasenovec T, Radosinska J, Torok J, Cacanyiova S, Barancik M, Bartekova M. Quercetin Exerts Age-Dependent Beneficial Effects on Blood Pressure and Vascular Function, But Is Inefficient in Preventing Myocardial Ischemia-Reperfusion Injury in Zucker Diabetic Fatty Rats. Molecules 2020;25:E187. [PMID: 31906454 DOI: 10.3390/molecules25010187] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
69 Rossello X, Rodriguez-Sinovas A, Vilahur G, Crisóstomo V, Jorge I, Zaragoza C, Zamorano JL, Bermejo J, Ordoñez A, Boscá L, Vázquez J, Badimón L, Sánchez-Margallo FM, Fernández-Avilés F, Garcia-Dorado D, Ibanez B. CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions. Sci Rep 2019;9:20290. [PMID: 31889088 DOI: 10.1038/s41598-019-56613-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
70 Parra-Flores P, Riquelme JA, Valenzuela-Bustamante P, Leiva-Navarrete S, Vivar R, Cayupi-Vivanco J, Castro E, Espinoza-Pérez C, Ruz-Cortés F, Pedrozo Z, Lavandero S, Rodrigo R, Diaz-Araya G. The Association of Ascorbic Acid, Deferoxamine and N-Acetylcysteine Improves Cardiac Fibroblast Viability and Cellular Function Associated with Tissue Repair Damaged by Simulated Ischemia/Reperfusion. Antioxidants (Basel) 2019;8:E614. [PMID: 31817022 DOI: 10.3390/antiox8120614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
71 Davidson SM, Ferdinandy P, Andreadou I, Bøtker HE, Heusch G, Ibáñez B, Ovize M, Schulz R, Yellon DM, Hausenloy DJ, Garcia-Dorado D; CARDIOPROTECTION COST Action (CA16225). Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. J Am Coll Cardiol 2019;73:89-99. [PMID: 30621955 DOI: 10.1016/j.jacc.2018.09.086] [Cited by in Crossref: 214] [Cited by in F6Publishing: 288] [Article Influence: 71.3] [Reference Citation Analysis]
72 Elmadani M, Khan S, Tenhunen O, Magga J, Aittokallio T, Wennerberg K, Kerkelä R. Novel Screening Method Identifies PI3Kα, mTOR, and IGF1R as Key Kinases Regulating Cardiomyocyte Survival. J Am Heart Assoc 2019;8:e013018. [PMID: 31617439 DOI: 10.1161/JAHA.119.013018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
73 Soares ROS, Losada DM, Jordani MC, Évora P, Castro-E-Silva O. Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies. Int J Mol Sci 2019;20:E5034. [PMID: 31614478 DOI: 10.3390/ijms20205034] [Cited by in Crossref: 50] [Cited by in F6Publishing: 86] [Article Influence: 16.7] [Reference Citation Analysis]
74 Caccioppo A, Franchin L, Grosso A, Angelini F, D'Ascenzo F, Brizzi MF. Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration. Int J Mol Sci 2019;20:E5024. [PMID: 31614414 DOI: 10.3390/ijms20205024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
75 Baehr A, Klymiuk N, Kupatt C. Evaluating Novel Targets of Ischemia Reperfusion Injury in Pig Models. Int J Mol Sci 2019;20:E4749. [PMID: 31557793 DOI: 10.3390/ijms20194749] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
76 Lejay A, Chakfé N. Protective Pathways in Ischaemia-Reperfusion: Take the RISK or Lose the Chance. Eur J Vasc Endovasc Surg 2020;59:108. [PMID: 31481301 DOI: 10.1016/j.ejvs.2019.07.022] [Reference Citation Analysis]
77 Ahmed N. Cardioprotective mechanism of FTY720 in ischemia reperfusion injury. J Basic Clin Physiol Pharmacol 2019;30. [PMID: 31469655 DOI: 10.1515/jbcpp-2019-0063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
78 Naryzhnaya NV, Maslov LN, Oeltgen PR. Pharmacology of mitochondrial permeability transition pore inhibitors. Drug Dev Res 2019;80:1013-30. [DOI: 10.1002/ddr.21593] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
79 Jahandiez V, Cour M, Abrial M, Loufouat J, Ovize M, Argaud L. Therapeutic Hypothermia After Cardiac Arrest: Involvement of the Risk Pathway in Mitochondrial PTP-Mediated Neuroprotection. Shock 2019;52:224-9. [DOI: 10.1097/shk.0000000000001234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
80 Rossello X, Lobo-Gonzalez M, Ibanez B. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome. Eur Heart J Acute Cardiovasc Care 2019;8:443-56. [PMID: 31172789 DOI: 10.1177/2048872619845283] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 7.7] [Reference Citation Analysis]
81 Schanze N, Bode C, Duerschmied D. Platelet Contributions to Myocardial Ischemia/Reperfusion Injury. Front Immunol 2019;10:1260. [PMID: 31244834 DOI: 10.3389/fimmu.2019.01260] [Cited by in Crossref: 22] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
82 Davidson SM, Yellon DM. Cardioprotection - is no the answer? A renewed look at nitric oxide signalling in cardiomyocytes. Cardiovasc Res 2018;114:773-5. [PMID: 29584817 DOI: 10.1093/cvr/cvy073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
83 Brand CS, Lighthouse JK, Trembley MA. Protective transcriptional mechanisms in cardiomyocytes and cardiac fibroblasts. J Mol Cell Cardiol 2019;132:1-12. [PMID: 31042488 DOI: 10.1016/j.yjmcc.2019.04.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
84 Song J, Zhao W, Lu C, Shao X. LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib-mediated death via inhibiting the AMPK-Mfn2 signaling pathway. Cancer Cell Int 2019;19:60. [PMID: 30923462 DOI: 10.1186/s12935-019-0778-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
85 Zhou J, Zhang S, Li Z, Chen Z, Xu Y, Ye W, He Z. Yap-Hippo promotes A549 lung cancer cell death via modulating MIEF1-related mitochondrial stress and activating JNK pathway. Biomed Pharmacother 2019;113:108754. [PMID: 30875659 DOI: 10.1016/j.biopha.2019.108754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
86 Li X, Wu M, An D, Yuan H, Li Z, Song Y, Liu Z. Suppression of Tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2-mediated mitochondrial fission. J Cell Physiol 2019. [PMID: 30741413 DOI: 10.1002/jcp.28287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
87 Chang W, Feng M, Li Y, Sun Y, Sun L. MKP1 overexpression reduces TNF-α-induced cardiac injury via suppressing mitochondrial fragmentation and inhibiting the JNK-MIEF1 pathways. J Cell Physiol 2019. [PMID: 30740674 DOI: 10.1002/jcp.28273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
88 Tyagi S, Singh N, Virdi JK, Jaggi AS. Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms. J Physiol Biochem 2019;75:19-28. [DOI: 10.1007/s13105-019-00664-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
89 Zhang Y, Wang Y, Xu J, Tian F, Hu S, Chen Y, Fu Z. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways. J Pineal Res 2019;66:e12542. [PMID: 30516280 DOI: 10.1111/jpi.12542] [Cited by in Crossref: 83] [Cited by in F6Publishing: 141] [Article Influence: 27.7] [Reference Citation Analysis]
90 Alakoski T, Ulvila J, Yrjölä R, Vainio L, Magga J, Szabo Z, Licht JD, Kerkelä R. Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia-reperfusion injury. Basic Res Cardiol 2019;114:7. [PMID: 30635790 DOI: 10.1007/s00395-018-0713-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
91 Lan S, Liu J, Luo X, Bi C. Effects of melatonin on acute brain reperfusion stress: role of Hippo signaling pathway and MFN2-related mitochondrial protection. Cell Stress Chaperones 2019;24:235-45. [PMID: 30632064 DOI: 10.1007/s12192-018-00960-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
92 Yao S, Yan W. Overexpression of Mst1 reduces gastric cancer cell viability by repressing the AMPK-Sirt3 pathway and activating mitochondrial fission. Onco Targets Ther 2018;11:8465-79. [PMID: 30555239 DOI: 10.2147/OTT.S180851] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
93 Wei N, Pu Y, Yang Z, Pan Y, Liu L. Therapeutic effects of melatonin on cerebral ischemia reperfusion injury: Role of Yap-OPA1 signaling pathway and mitochondrial fusion. Biomed Pharmacother 2019;110:203-12. [PMID: 30476721 DOI: 10.1016/j.biopha.2018.11.060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
94 Xie Y, Lv Y, Zhang Y, Liang Z, Han L, Xie Y. LATS2 promotes apoptosis in non-small cell lung cancer A549 cells via triggering Mff-dependent mitochondrial fission and activating the JNK signaling pathway. Biomed Pharmacother 2019;109:679-89. [PMID: 30551520 DOI: 10.1016/j.biopha.2018.10.097] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
95 Wan J, Cui J, Wang L, Wu K, Hong X, Zou Y, Zhao S, Ke H. Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathways. Cancer Cell Int 2018;18:165. [PMID: 30377412 DOI: 10.1186/s12935-018-0665-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
96 Li H, Feng J, Zhang Y, Feng J, Wang Q, Zhao S, Meng P, Li J. Mst1 deletion attenuates renal ischaemia-reperfusion injury: The role of microtubule cytoskeleton dynamics, mitochondrial fission and the GSK3β-p53 signalling pathway. Redox Biol 2019;20:261-74. [PMID: 30384260 DOI: 10.1016/j.redox.2018.10.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
97 Davidson SM, Arjun S, Basalay MV, Bell RM, Bromage DI, Bøtker HE, Carr RD, Cunningham J, Ghosh AK, Heusch G, Ibanez B, Kleinbongard P, Lecour S, Maddock H, Ovize M, Walker M, Wiart M, Yellon DM. The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection-evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology. Basic Res Cardiol 2018;113:43. [PMID: 30310998 DOI: 10.1007/s00395-018-0704-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 14.8] [Reference Citation Analysis]
98 Tinker A, Aziz Q, Li Y, Specterman M. ATP‐Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles. In: Terjung R, editor. Comprehensive Physiology. Wiley; 2011. pp. 1463-511. [DOI: 10.1002/cphy.c170048] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 10.5] [Reference Citation Analysis]
99 Liu J, Yan W, Zhao X, Jia Q, Wang J, Zhang H, Liu C, He K, Sun Z. Sirt3 attenuates post-infarction cardiac injury via inhibiting mitochondrial fission and normalization of AMPK-Drp1 pathways. Cell Signal 2019;53:1-13. [PMID: 30219671 DOI: 10.1016/j.cellsig.2018.09.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
100 Wei R, Cao J, Yao S. Matrine promotes liver cancer cell apoptosis by inhibiting mitophagy and PINK1/Parkin pathways. Cell Stress Chaperones 2018;23:1295-309. [PMID: 30209783 DOI: 10.1007/s12192-018-0937-7] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
101 Sheng J, Li H, Dai Q, Lu C, Xu M, Zhang J, Feng J. DUSP1 recuses diabetic nephropathy via repressing JNK‐Mff‐mitochondrial fission pathways. J Cell Physiol 2018;234:3043-57. [DOI: 10.1002/jcp.27124] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
102 Zhou H, Wang J, Hu S, Zhu H, Toanc S, Ren J. BI1 alleviates cardiac microvascular ischemia-reperfusion injury via modifying mitochondrial fission and inhibiting XO/ROS/F-actin pathways. J Cell Physiol 2019;234:5056-69. [PMID: 30256421 DOI: 10.1002/jcp.27308] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 13.3] [Reference Citation Analysis]
103 Wang Y, Sun X, Ji K, Du L, Xu C, He N, Wang J, Liu Y, Liu Q. Sirt3-mediated mitochondrial fission regulates the colorectal cancer stress response by modulating the Akt/PTEN signalling pathway. Biomedicine & Pharmacotherapy 2018;105:1172-82. [DOI: 10.1016/j.biopha.2018.06.071] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
104 Cao J, Wei R, Yao S. Matrine has pro-apoptotic effects on liver cancer by triggering mitochondrial fission and activating Mst1-JNK signalling pathways. J Physiol Sci 2019;69:185-98. [PMID: 30155612 DOI: 10.1007/s12576-018-0634-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
105 Xu P, Zhang G, Sha L, Hou S. DUSP1 alleviates cerebral ischaemia reperfusion injury via inactivating JNK-Mff pathways and repressing mitochondrial fission. Life Sci 2018;210:251-62. [PMID: 30138595 DOI: 10.1016/j.lfs.2018.08.049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
106 Song Y, Zhong C, Wang X. Heat shock protein 70: A promising therapeutic target for myocardial ischemia–reperfusion injury. J Cell Physiol 2019;234:1190-207. [DOI: 10.1002/jcp.27110] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
107 Ji K, Lin K, Wang Y, Du L, Xu C, He N, Wang J, Liu Y, Liu Q. TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway. Cancer Cell Int 2018;18:117. [PMID: 30127666 DOI: 10.1186/s12935-018-0615-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
108 Singhanat K, Apaijai N, Chattipakorn SC, Chattipakorn N. Roles of melatonin and its receptors in cardiac ischemia–reperfusion injury. Cell Mol Life Sci 2018;75:4125-49. [DOI: 10.1007/s00018-018-2905-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
109 Bernhagen J. "Remote" myokine protects from pulmonary ischemia/reperfusion injury by a surprising "proximal" control mechanism. Ann Transl Med 2018;6:275. [PMID: 30094261 DOI: 10.21037/atm.2018.05.45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
110 Jovanović A. Cardioprotective signalling: Past, present and future. Eur J Pharmacol 2018;833:314-9. [PMID: 29935170 DOI: 10.1016/j.ejphar.2018.06.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
111 Zhou H, Wang S, Hu S, Chen Y, Ren J. ER-Mitochondria Microdomains in Cardiac Ischemia-Reperfusion Injury: A Fresh Perspective. Front Physiol. 2018;9:755. [PMID: 29962971 DOI: 10.3389/fphys.2018.00755] [Cited by in Crossref: 94] [Cited by in F6Publishing: 104] [Article Influence: 23.5] [Reference Citation Analysis]
112 Pottecher J, Adamopoulos C, Lejay A, Bouitbir J, Charles AL, Meyer A, Singer M, Wolff V, Diemunsch P, Laverny G, Metzger D, Geny B. Diabetes Worsens Skeletal Muscle Mitochondrial Function, Oxidative Stress, and Apoptosis After Lower-Limb Ischemia-Reperfusion: Implication of the RISK and SAFE Pathways? Front Physiol 2018;9:579. [PMID: 29872405 DOI: 10.3389/fphys.2018.00579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
113 Skyschally A, Kleinbongard P, Lieder H, Gedik N, Stoian L, Amanakis G, Elbers E, Heusch G. Humoral transfer and intramyocardial signal transduction of protection by remote ischemic perconditioning in pigs, rats, and mice. Am J Physiol Heart Circ Physiol. 2018;315:H159-H172. [PMID: 29569956 DOI: 10.1152/ajpheart.00152.2018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 6.5] [Reference Citation Analysis]
114 Zhou H, Ma Q, Zhu P, Ren J, Reiter RJ, Chen Y. Protective role of melatonin in cardiac ischemia-reperfusion injury: From pathogenesis to targeted therapy. J Pineal Res 2018;64:e12471. [DOI: 10.1111/jpi.12471] [Cited by in Crossref: 127] [Cited by in F6Publishing: 139] [Article Influence: 31.8] [Reference Citation Analysis]